Julie Elaine Burke

Array ( [id] => 3736408 [patent_doc_number] => 05785974 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'Synthetic peptides and vaccines against parvovirus' [patent_app_type] => 1 [patent_app_number] => 8/307724 [patent_app_country] => US [patent_app_date] => 1994-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10784 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/785/05785974.pdf [firstpage_image] =>[orig_patent_app_number] => 307724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998029 [patent_doc_number] => 06004535 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Methods of imaging neoplastic disease and of detecting and quantifying MN protein/polypeptide using MN-specific antibodies' [patent_app_type] => 1 [patent_app_number] => 8/335469 [patent_app_country] => US [patent_app_date] => 1994-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 21 [patent_no_of_words] => 20584 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004535.pdf [firstpage_image] =>[orig_patent_app_number] => 335469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943374 [patent_doc_number] => 05981726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Chimeric and mutationally stabilized tumor-specific B1, B3 and B5 antibody fragments; immunotoxic fusion proteins; and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/331397 [patent_app_country] => US [patent_app_date] => 1994-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 31 [patent_no_of_words] => 28617 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981726.pdf [firstpage_image] =>[orig_patent_app_number] => 331397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4005245 [patent_doc_number] => 05888773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Method of producing single-chain Fv molecules' [patent_app_type] => 1 [patent_app_number] => 8/292124 [patent_app_country] => US [patent_app_date] => 1994-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11374 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888773.pdf [firstpage_image] =>[orig_patent_app_number] => 292124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730458 [patent_doc_number] => 05698204 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Recombinant allergenic proteins from ragweed pollen' [patent_app_type] => 1 [patent_app_number] => 8/290448 [patent_app_country] => US [patent_app_date] => 1994-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 15514 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698204.pdf [firstpage_image] =>[orig_patent_app_number] => 290448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3934204 [patent_doc_number] => 05972703 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Bone precursor cells: compositions and methods' [patent_app_type] => 1 [patent_app_number] => 8/289794 [patent_app_country] => US [patent_app_date] => 1994-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 21475 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972703.pdf [firstpage_image] =>[orig_patent_app_number] => 289794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4214586 [patent_doc_number] => 06039947 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Peptides derived from immunodominant epitopes of myelin basic protein' [patent_app_type] => 1 [patent_app_number] => 8/297395 [patent_app_country] => US [patent_app_date] => 1994-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 13524 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/039/06039947.pdf [firstpage_image] =>[orig_patent_app_number] => 297395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3665212 [patent_doc_number] => 05599708 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Osteoclast growth regulating factors and antibodies' [patent_app_type] => 1 [patent_app_number] => 8/279675 [patent_app_country] => US [patent_app_date] => 1994-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 9850 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599708.pdf [firstpage_image] =>[orig_patent_app_number] => 279675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622674 [patent_doc_number] => 05607847 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Recombinant human anti-human immunodeficiency virus antibody' [patent_app_type] => 1 [patent_app_number] => 8/275053 [patent_app_country] => US [patent_app_date] => 1994-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8058 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/607/05607847.pdf [firstpage_image] =>[orig_patent_app_number] => 275053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770868 [patent_doc_number] => 05807715 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin' [patent_app_type] => 1 [patent_app_number] => 8/266154 [patent_app_country] => US [patent_app_date] => 1994-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9201 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807715.pdf [firstpage_image] =>[orig_patent_app_number] => 266154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3764934 [patent_doc_number] => 05733553 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Recombinant birth control vaccine' [patent_app_type] => 1 [patent_app_number] => 8/263483 [patent_app_country] => US [patent_app_date] => 1994-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 3152 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/733/05733553.pdf [firstpage_image] =>[orig_patent_app_number] => 263483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3999519 [patent_doc_number] => 05922847 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Methods of purifying hematopoietic cells using an antibody to a stem cell factor receptor' [patent_app_type] => 1 [patent_app_number] => 8/255193 [patent_app_country] => US [patent_app_date] => 1994-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8800 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922847.pdf [firstpage_image] =>[orig_patent_app_number] => 255193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3644510 [patent_doc_number] => 05639462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Attenuated polyiviruses vaccine containing them and vaccination methods using them' [patent_app_type] => 1 [patent_app_number] => 8/239858 [patent_app_country] => US [patent_app_date] => 1994-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2354 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639462.pdf [firstpage_image] =>[orig_patent_app_number] => 239858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3697181 [patent_doc_number] => 05618920 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Modular assembly of antibody genes, antibodies prepared thereby and use' [patent_app_type] => 1 [patent_app_number] => 8/235225 [patent_app_country] => US [patent_app_date] => 1994-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 63 [patent_no_of_words] => 34513 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618920.pdf [firstpage_image] =>[orig_patent_app_number] => 235225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4098530 [patent_doc_number] => 06051226 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'MN-specific antibodies and their use in cancer treatment' [patent_app_type] => 1 [patent_app_number] => 8/177093 [patent_app_country] => US [patent_app_date] => 1993-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 27693 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051226.pdf [firstpage_image] =>[orig_patent_app_number] => 177093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4072033 [patent_doc_number] => 05965405 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Method for producing Fv fragments in eukaryotic cells' [patent_app_type] => 1 [patent_app_number] => 8/165530 [patent_app_country] => US [patent_app_date] => 1993-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 4203 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965405.pdf [firstpage_image] =>[orig_patent_app_number] => 165530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693103 [patent_doc_number] => 05676951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Bovine herpesvirus type 1 deletion mutants and vaccines' [patent_app_type] => 1 [patent_app_number] => 8/150203 [patent_app_country] => US [patent_app_date] => 1993-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 15437 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/676/05676951.pdf [firstpage_image] =>[orig_patent_app_number] => 150203 [rel_patent_id] =>[rel_patent_doc_number] =>)